Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

This study has been completed.
Sponsor:
Collaborator:
VA Office of Research and Development
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00023348
First received: September 6, 2001
Last updated: September 9, 2005
Last verified: September 2005